Novo Nordisk (NVO) returns
Novo Nordisk returns over 10 years
$1,000 invested in Novo Nordisk ten years ago was worth $2,774 at the close on October 30, 2026, with dividends reinvested: an average return of 10.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +5.5% | — | $1,055 | -0.9% |
| 3 months | -21.5% | — | $785.05 | +2.1% |
| Year to date | -17.6% | — | $823.78 | +11.7% |
| 1 year | -16.2% | — | $837.61 | +12.4% |
| 3 years | -54.9% | -23.3% | $451.43 | +88.5% |
| 5 years | -18.8% | -4.1% | $812.46 | +76.0% |
| 10 years | +177.4% | +10.7% | $2,774 | +316.6% |
Novo Nordisk return by calendar year
| Year | NVO | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -17.6% | +11.7% | -29.3% |
| 2025 | -39.3% | +17.7% | -57.0% |
| 2024 | -15.9% | +24.9% | -40.8% |
| 2023 | +54.8% | +26.2% | +28.6% |
| 2022 | +22.7% | -18.2% | +40.8% |
| 2021 | +63.5% | +28.7% | +34.7% |
| 2020 | +23.3% | +18.4% | +4.9% |
| 2019 | +28.7% | +31.2% | -2.5% |
| 2018 | -13.0% | -4.6% | -8.4% |
| 2017 | +53.0% | +21.7% | +31.3% |
| 2016 | -37.0% | +12.0% | -49.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: NVO financials · NVO valuation
No forecast, no recommendation. This page describes Novo Nordisk from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.